Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene, which codes for a multi-domain protein kinase, are considered the most common genetic cause of late-onset autosomal-dominant Parkinson's disease. This full-length, purified and active wild type LRRK2 protein may be useful in research to better understand the native protein, unaffected by mutations, as well as to explore the mechanisms underlying the disease.
• Increase disease relevance
by interrogating a purified and active full-length LRRK2 protein
• Uncover novel compounds
or hits specific to the full-length form
• Advance Parkinson's research
using the full-length protein and validated assays Related Product: LanthaScreen® Kinase Activity Assay
—measure kinase activity using the fluorescein-ERM (LRRKtide) substrate and LanthaScreen® Tb-pERM antibody, in an addition-only TR-FRET assay.
• LRRK2 tools for advancing Parkinson's disease research
• Kinase protein portfolio
• LanthaScreen® Eu Kinase Binding Assay
• LanthaScreen® Activity Assay